NASDAQ:VERV
Delisted

Verve Therapeutics Stock Forecast

etoro logo Buy VERV
*Your capital is at risk
$11.13
+0 (+0%)
At Close: Oct 24, 2025

VERV Performance

FAQ

What is the symbol for Verve Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Verve Therapeutics, Inc. is VERV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Verve Therapeutics, Inc. Stock?
Based on market data through Oct 24, 2025, StockInvest.us rates Verve Therapeutics, Inc. (VERV) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Jun 02, 2025, the price has risen 132.12%. The current 3-month trend forecast projects flat movement.

How to buy Verve Therapeutics, Inc. Stock?
Verve Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Verve Therapeutics, Inc. Stock.

What's the current price of Verve Therapeutics, Inc. Stock?
As of the end of day on the Oct 24, 2025, the price of an Verve Therapeutics, Inc. (VERV) share was $11.13.

What is the 52-week high and low for Verve Therapeutics, Inc. Stock?
The 52-week high for Verve Therapeutics, Inc. Stock is $11.40 and the 52-week low is $2.86.

What is the market capitalization of Verve Therapeutics, Inc. Stock?
As of the Oct 24, 2025, the market capitalization of Verve Therapeutics, Inc. is 994.045M.
Click to get the best stock tips daily for free!
ABOUT VERVE THERAPEUTICS, INC.
Verve Therapeutics
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with...
GOLDEN STAR
Ticker Change Signal Date
N
NXDR
$2.27
7.93% Aug 03
MC
$67.08
3.53% Jul 31
FCX
$62.63
10.79% Jul 31
ARW
$212.85
6.58% Jul 30
BIIB
$202.19
2.20% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE